Dna encoding 5-ht4 serotonin receptors and uses thereof
CA 2129969 C · Owner: Weinshank, Richard L. · Inventors: Gerald, Christophe; Hartig, Paul R.; Branchek, Theresa A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides an isolated nucleic acid molecule encoding mammalian 5- HT4 and an isolated nucleic acid molecule encoding a human 5-HT4 receptor, an isolated protein which is a mammalian 5- HT4 receptor, an isolated which is a human 3-HT4 receptor, vectors comprising an isolated nucleic acid molecule encoding a mammalian 5-HT4 receptor, vectors comprising an isolated nucleic acid molecule encoding a human 5-HT4 receptor mammalian cells comprising such , vectors antibodies directed to the 5-HT4 receptor nucleic, acid probes useful for detecting nucleic acid encoding a mammalian or human 5- HT4 receptor, antisense oligonucleotides complementary to any sequences of a nucleic acid …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 22, 1993 and granted May 16, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 22, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 22, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.